Reducing human suffering by detecting cancer earlier with patented technology

BioCurex's RECAF(tm) marker is found in all types of major cancers

Free
Message: Abbott Pub. Number WO2009006323

Abbott Pub. Number WO2009006323

posted on Mar 25, 2009 02:30PM
3/9/09 - METHODS AND MARKER COMBINATIONS FOR SCREENING FOR PREDISPOSITION TO LUNG CANCER
 RUSSELL, John, C.
              COLPITTS, Tracey
              RUSSELL, Eric, L.
              FROST, Stephen
              RAMIREZ, Javier
              SINGH, Bhawani
              RUSSELL, John, C.
Title         METHODS AND MARKER COMBINATIONS FOR SCREENING FOR PREDISPOSITION TO LUNG CANCER
Abstract      The present invention relates to rapid, sensitive methods for determining whether a subject has or is at risk of developing lung cancer based on certain combinations of biomarkers, or biomarkers and biometric parameters. The methods consist of: a) quantifying in a test sample obtained from a subject, the amount of two or more biomarkers in a panel, the panel comprising at least one antibody and at least one antigen: b) comparing the amount of each biomarker quantified in the panel to a predetermined cutoff for said biomarker and assigning a score for each biomarker based on said comparison: c) combining the assigned score for each biomarker quantified in step b to obtain a total score for said subject: d) comparing the total score in step c with a predetermined total score and e) determining whether said subject has a risk of lung cancer based on the comparison in step d.

If you would like to purchase a copy of this patent, please call MicroPatent at 800-648-6787.
Share
New Message
Please login to post a reply